Archives for the 'Blog' Category
NuVasive to Acquire Osteocel Biologics Business from Osiris Therapeutics
The $200 million NuVasive raised in a March offering may soon be put to good use. The company announced yesterday the pending acquisition of the Osteocel biologics business from Osiris Therapeutics.
Osteocel is a bone matrix product containing stem cells. Like an autograft, it is biologically active and provides the beneficial properties of osteoconduction, osteoinduction, and […]
Myriad Goes Direct (Again)
Myriad Genetic Laboratories develops and markets proprietary predictive and personalized medicine products. This includes the poorly branded BRACAnalysis, to assess a woman’s risk of developing breast or ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes. The test is reimbursed by most insurance carriers and is recommended for women with a […]
South Korean FDA Approves Cynosure’s Accolade Workstation for Pigmented Lesions
Although freckles occur most often in light skinned individuals with blond hair and blue eyes, freckles are also common among Asians, including Koreans. While they can look good, I’ve learned in my 25 years to never get between a woman and her happiness.
Cynosure, based in Westford, MA, offers an array of laser-based aesthetic treatment systems. […]
BioElectronics Corp. Merits a First Look
Most investors won’t touch a stock trading on the pink sheets with a ten foot medical device. But for the risk-inclined among you, BioElectronics Corp. (BIEL) may warrant a first look.
The company, which has gone largely unnoticed by investors, is trading near its year-long low, despite management initiatives that have already begun to pay off.
Based […]
[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications.
Bioject’s technology works by forcing liquid medication at high speed through a tiny orifice (smaller than a human hair) held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin in a fraction of a second. Several studies have […]
Bad News for Blood Substitutes
Blood substitutes don’t require refrigeration or cross-matching, have a long shelf life, and reduce the risk of iatrogenic infection. They could be a potentially lifesaving option for surgical and trauma patients with hemorrhagic shock, especially in rural areas and military settings where access to donor blood is limited.
Despite the potential advantages, clinical trials have raised […]
CryoLife on Firm Footing: EPS Increases, Revenues Up, Raises Guidance
Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or $0.10 per share, compared to $1.4 million, or $0.04 per share in Q1 2007.
Tissue processing revenues in Q1 2008 increased 4% to $13.4 million, primarily due to increased demand for the company’s cardiac and vascular […]
NeuroMetrix Receives FDA 510(k) Clearance for Advance
Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat System, received FDA 510(k) clearance for the Advance System this week. Shares of the Waltham, MA-based company nearly doubled on the news, to a high of $3.06 on Monday.
Advance is a platform for performing nerve […]
[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines.
VacciMax technology is based on a novel approach to the use of liposomes. While liposomes typically contribute only marginally to the production of an immune response, IVT has discovered that liposomes stabilized by VacciMax technology significantly enhance antibody production.
The company believes […]
Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth
The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade and appears to be holding its own now. An aging demographic virtually guarantees increased demand for healthcare supplies.
Not surprisingly, the sector is also highly competitive. J&J, Boston Scientific and Medtronic are industry behemoths with a […]
